Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status by Pett, SL, Spyer, M, Haddow, L, Nhema, R, Benjamin, L, Najjuka, G, Bilima, S, Daud, I, Musoro, G, Kitabalwa, J, Selemani, G, Kandie, S, Cornelius, KM, Katemba, C, Berkley, J, Hassan, A, Kityo, C, Hakim, J, Heyderman, R, Gibb, DM, Walker, AS